Results of a study funded by PCRF have shown how ‘machine learning’, a branch of artificial intelligence, has the potential to identify which people are more likely to develop pancreatic cancer up to two years before they are diagnosed.
The UK’s national tissue bank for pancreatic diseases is open for applications from any UK-based researchers needing samples of blood, urine and saliva to aid their research.
PCRF has accepted an invitation to be a partner in a research programme that will treat 75 patients with locally advanced pancreatic cancer with the latest high-tech radiotherapy technology.
A pilot study funded by PCRF has shown that by analysing electronic health records with sophisticated computer modelling techniques, it is possible to identify people at risk of developing pancreatic cancer up to 20 months before their diagnosis.
The foot-and-mouth-disease virus is helping scientists to tackle pancreatic cancer, in new research funded by PCRF. (Image credit: CRUK)
A PCRF-funded project has identified a new way to kill pancreatic cancer cells by ‘pulling the plug’ on the energy generator that fuels calcium pumps on their cell surface.
Some 150 people attended the 2019 PCRF Supporters Conference at the Cavendish Conference Centre in London on 29 November.
A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients.
Treatment of pancreatic cancer might be enhanced by zapping tumours with electricity alongside drug treatments, according to a PCRF-funded project at University College Cork.
PCRF-funded scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion.